This article is more than 5 years old. Information may no longer be current.
Fresenius Medical Care appoints new CEO
Fresenius Medical Care CEO Ronald Kuerbitz has left the dialysis product and service provider to head up new health care services and technology company agilon health. Fresenius appointed William Valle as his successor, effective January 16.
Since 2014, Valle served as executive vice president responsible for the Dialysis Service Business of Fresenius Medical Care North America (FMCNA), the largest business segment of the company, as well as the Vascular Access business.
Valle joined FMCNA in 2009 with 22 years' experience in the dialysis industry, holding executive positions at several dialysis companies including Gambro Healthcare, Inc.
Register for NN&I’s live roundtable on MACRA, featuring Adam Weinstein, MD, and Diana Strubler, Policy and Standards Senior Manager at Acumen Physician Solutions
Date: Thursday, February 23, 2017 Time: 2:00 PM Central Standard Time Duration: 1 hour
Kuerbitz will remain with FMC until mid-February and will assist in the leadership transition during that time.
“Fresenius Medical Care and agilon health share a vision for making health care more effective by empowering patients and caregivers with the administrative, technology and management resources that enable them to focus the right resources on the right patient at the right time and place, although in different areas of the health care sector,” said Kuerbitz. “That focus is essential to the transition from fee-for-service to value-based care – and is the path to better outcomes, better experiences and better economics for all participants in the system.”